Advertisement
Advertisement

EDSA

EDSA logo

Edesa Biotech Inc

1.84
USD
-0.03
-1.60%
Dec 18, 15:37 UTC -5
Closed
...

Edesa Biotech Inc Profile

About

Edesa Biotech Inc. is a biopharmaceutical company. It is focused on acquiring, developing and commercializing clinical stage drugs for dermatological and gastrointestinal indications with clear unmet medical needs. The company's product pipeline consists of EB01, EB02 and EB04 which are in clinical stage. Edesa Biotech Inc., formerly known as Stellar Biotechnologies Inc., is based in TORONTO.

Info & Links

CEO

Pardeep Nijhawan

Headquarters

100 SPY COURT
MARKHAM, A6 L3R 5H6, CANADA

Industry

Pharmaceuticals Major

Sector

Health Technology

Website

www.edesabiotech.com

Auditor

MNP LLP

Share holders

13

Employees

16

Edesa Biotech Inc Statistics

Valuation Measures

Market Capitalization2

5.98M

Enterprise Value

3.94M

Enterprise Value/EBITDA(ttm)

-0.48

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

2.17

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-137.95%

Return on Invested Capital(ttm)

-154.35%

Return on Assets(ttm)

-97.48%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-8.19M

Net Income Available to Common(ttm)

-6.93M

Diluted EPS(ttm)

-1.93

Share Statistics

Beta (5Y Monthly)

0.77

52-Week Change

-45.56%

S&P 500 52-Week Change

23.87%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

3.25M

Dividend Yield

0.00%

Float4

2.44M

% Held by Insiders

25.00%

% Held by Institutions

5.50%

Balance Sheet

Total Cash(mrq)

2.04M

Total Cash Per Share(mrq)

0.63

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

1.29%

Quick Ratio(mrq)

1.29%

Book Value Per Share(mrq)

0.88

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.22

Free Cash Flow(ytd)

-3.92M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement